Determinants of versican-v1 proteoglycan processing by the metalloproteinase ADAMTS5

Journal of Biological Chemistry

Volumn 289, Issue 40, 2014, Pages 27859-27873

  Foulcer, Simon J ^a   Nelson, Courtney M ^a   Quintero, Maritza V ^b   Kuberan, Balagurunathan ^b   Larkin, Jonathan ^c   Dours Zimmermann, Maria T ^d   Zimmermann, Dieter R ^d   Apte, Suneel S ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^c GLAXOSMITHKLINE   (United States)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

METALLOPROTEINASES; PROTEOGLYCANS;

AGGRECANASE 2; ALANINE; CHONDROITIN ABC LYASE; CHONDROITIN SULFATE; GLUTAMIC ACID; GLYCINE; SERINE; THREONINE; UNCLASSIFIED DRUG; VERSICAN; VERSICAN V1; ADAM PROTEIN; ADAMTS1 PROTEIN, HUMAN; ADAMTS5 PROTEIN, HUMAN; PROTEIN BINDING; VCAN PROTEIN, HUMAN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; EMBRYO; GENE MUTATION; HUMAN; HUMAN CELL; MOLECULAR DOCKING; MOUSE; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN PROCESSING; SITE DIRECTED MUTAGENESIS; SKIN FIBROBLAST; CHEMISTRY; GENETICS; METABOLISM; PROTEIN MOTIF; PROTEIN TERTIARY STRUCTURE;

ADAM PROTEINS; AMINO ACID MOTIFS; CHONDROITIN SULFATES; HUMANS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTEOLYSIS; VERSICANS;

EID: 84907494680     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.573287     Document Type: Article

References (70)

1. Yamaguchi, Y. (2000) Lecticans: organizers of the brain extracellular matrix. Cell Mol. Life Sci. 57, 276 -289
2. Zimmermann, D. R., and Ruoslahti, E. (1989) Multiple domains of the large fibroblast proteoglycan, versican. EMBO J. 8, 2975-2981
3. LeBaron, R. G., Zimmermann, D. R., and Ruoslahti, E. (1992) Hyaluronate binding properties of versican. J. Biol. Chem. 267,10003-10010
4. K., and Watanabe, H. (2003) Distinct interaction of versican/PG-M with hyaluronan and link protein, J. Biol. Chem. 278, 41205-41212
5. Shi, S., Grothe, S., Zhang, Y., O'Connor-McCourt, M. D., Poole, A. R., Roughley, P. J., and Mort, J. S. (2004) Link protein has greater affinity for versican than aggrecan. J. Biol. Chem. 279,12060-12066
6. Aspberg, A., Adam, S., Kostka, G., Timpl, R., and Heinegård, D. (1999) Fibulin-1 is a ligand for the C-type lectin domains of aggrecan and versican. J. Biol. Chem. 274, 20444-20449
7. Aspberg, A., Binkert, C., and Ruoslahti, E. (1995) The versican C-type lectin domain recognizes the adhesion protein tenascin-R. Proc. Natl. Acad. Sci. U.S.A. 92,10590-10594
8. Isogai, Z., Aspberg, A., Keene, D.R., Ono, R. N., Reinhardt, D. P., and Sakai, L. Y. (2002) Versican interacts with fibrillin-1 and links extracellular microfibrils to other connective tissue networks. J. Biol. Chem. 277, 4565-4572
9. Evanlco, S. P., Angello, J. C., and Wight, T. N. (1999) Formation of hyaluronanand versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells. Arterioscler. Thromb. Vase. Biol. 19,1004-1013
10. Hattori, N., Carrino, D. A., Lauer, M. E., Vasanji, A., Wylie, J. D., Nelson, C. M., and Apte, S. S. (2011) Pericellular versican regulates the fibroblast- myofibroblast transition: a role for ADAMTS5 protease-mediated proteolysis. J. Biol Chem. 286, 34298-34310
11. Matsumoto, K., Kamiya, N., Suwan, K., Atsumi, F., Shimizu, K., Shinomura, T., Yamada, Y., Kimata, K., and Watanabe, H. (2006) Identification and characterization of versican/PG-M aggregates in cartilage. J. Biol. Chem. 281,18257-18263
12. Cattaruzza, S., Schiappacassi, M., Ljungberg-Rose, A., Spessotto, P., Perissinotto, D., Mörgelin, M., Mucignat, M. T., Colombatti, A., and Perris, R. (2002) Distribution of PG-M/versican variants in human tissues and de novo expression of isoform V3 upon endothelial cell activation, migration, and neoangiogenesis in vitro. J. Biol. Chem. 277, 47626-47635
13. Henderson, D. J., and Copp, A. J. (1998) Versican expression is associated with chamber specification, septation, and valvulogenesis in the developing mouse heart. Circ. Res. 83, 523-532
14. Zimmermann, D. R., Dours-Zimmermann, M. T., Schubert, M., and Bruckner-Tuderman, L. (1994) Versican is expressed in the proliferating zone in the epidermis and in association with the elastic network of the dermis. J. Cell Biol. 124, 817-825
15. Choocheep, K., Hatano, S., Takagi, H., Watanabe, H., Kimata, K., and Kongtawelert, P. (2010) Versican facilitates chondrocyte differentiation and regulates joint morphogenesis. J. Biol. Chem. 285, 21114-21125
16. Enomoto, H., Nelson, C. M., Somerville, R. P., Mielke, K., Dixon, L. J., Powell, K., and Apte, S. S. (2010) Cooperation of two AD AMTS metalloproteases in closure of the mouse palate identifies a requirement for versican proteolysis in regulating palatal mesenchyme proliferation. Development 137, 4029-4038
17. McCulloch, D. R., Nelson, C. M., Dixon, L. J., Silver, D. L., Wylie, J. D., Lindner, V., Sasaki, T., Cooley, M. A., Argraves, W. S., and Apte, S. S. (2009) AD AMTS metalloproteases generate active versican fragments that regulate interdigital web regression. Dev. Cell 17, 687- 698
18. Mjaatvedt, C. H., Yamamura, H., Capehart, A. A., Turner, D., and Markwald, R. R. (1998) The Cspg2 gene, disrupted in the hdf mutant, is required for right cardiac chamber and endocardial cushion formation. Dev. Biol. 202,56-66
19. Nandadasa, S., Foulcer, S., and Apte, S. S. (2014) The multiple, complex roles of versican and its proteolytic turnover by AD AMTS proteases during embryogenesis. Matrix Biol. 35, 34-41
20. Perissinotto, D., Iacopetti, P., Bellina, I., Doliana, R., Colombatti, A., Pettway, Z., Bronner-Fraser, M., Shinomura, T., Kimata, K., Mörgelin, M., Löfberg, J., and Perris, R. (2000) Avian neural crest cell migration is diversely regulated by the two major hyaluronan-binding proteoglycans PG-M/versican and aggrecan. Development 127, 2823-2842
21. Snow, H. E., Riccio, L. M., Mjaatvedt, C. H., Hoffman, S., and Capehart, A. A. (2005) Versican expression during skeletal/joint morphogenesis and patterning of muscle and nerve in the embryonic mouse limb. Anat. Rec. A Discov. Mol. Cell Evol. Biol. 282, 95-105
22. Williams, D. R., Jr., Presar, A. R., Richmond, A. T., Mjaatvedt, C. H., Hoffman, S., and Capehart, A. A. (2005) Limb chondrogenesis is compromised in the versican deficient hdf mouse. Biochem. Biophys. Res. Commun. 334, 960-966
23. Yang, B. L., Yang, B. B., Erwin, M., Ang, L. C., Finkelstein, J., and Yee, A. J. (2003) Versican G3 domain enhances cellular adhesion and proliferation of bovine intervertebral disc cells cultured in vitro. Life Sci. 73,3399-3413
24. Yee, A. J., Akens, M., Yang, B. L., Finkelstein, J., Zheng, P. S., Deng, Z., and Yang, B. (2007) The effect of versican G3 domain on local breast cancer invasiveness and bony metastasis. Breast Cancer Res. 9, R47
25. Dutt, S., Kléber, M., Matasci, M., Sommer, L., and Zimmermann, D. R. (2006) Versican V0 and V1 guide migratory neural crest cells. J. Biol. Chem. 281,12123-12131
26. Bode-Lesniewska, B., Dours-Zimmermann, M. T., Odermatt, B. F., Briner, J., Heitz, P. U., and Zimmermann, D. R. (1996) Distribution of the large aggregating proteoglycan versican in adult human tissues. J. Histochem. Cytochem. 44, 303-312
27. Gao, D., Joshi, N., Choi, H., Ryu, S., Hahn, M., Catena, R., Sadik, H., Argani, P., Wagner, P., Vahdat, L. T., Port, J. L., Stiles, B., Sukumar, S., Altorki, N. K., Rafii, S., and Mittal, V. (2012) Myeloid progenitor cells in the premetastatic lung promote metastases by inducing mesenchymal to epithelial transition. Cancer Res. 72,1384-1394
28. Kischel, P., Waltregny, D., Dumont, B., Turtoi, A., Greffe, Y., Kirsch, S., De Pauw, E., and Castronovo, V. (2010) Versican overexpression in human breast cancer lesions: known and new isoforms for stromal tumor targeting. Int. J. Cancer 126, 640-650
29. Ricciardelli, C., Sakko, A. J., Ween, M. P., Russell, D. L., and Horsfall, D. J. (2009) The biological role and regulation of versican levels in cancer. Cancer Metastasis Rev. 28, 233-245
30. Dours-Zimmermann, M. T., and Zimmermann, D. R. (1994) A novel glycosaminoglycan attachment domain identified in two alternative splice variants of human versican. J. Biol. Chem. 269, 32992-32998
31. Lemire, J. M., Braun, K. R., Maurel, P., Kaplan, E. D., Schwartz, S. M., and Wight, T. N. (1999) Versican/PG-M isoforms in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 19,1630-1639
32. Shinomura, T., Nishida, Y., Ito, K., and Kimata, K. (1993) cDNA cloning of PG-M, a large chondroitin sulfate proteoglycan expressed during chondrogenesis in chick limb buds. Alternative spliced multiforms of PG-M and their relationships to versican. J. Biol. Chem. 268,14461-14469
33. Kern, C. B., Twal, W. O., Mjaatvedt, C. H., Fairey, S. E., Toole, B. P., Iruela-Arispe, M. L., and Argraves, W. S. (2006) Proteolytic cleavage of versican during cardiac cushion morphogenesis. Dev. Dyn. 235, 2238-2247
34. Landolt, R. M., Vaughan, L., Winterhalter, K. H., and Zimmermann, D. R. (1995) Versican is selectively expressed in embryonic tissues that act as barriers to neural crest cell migration and axon outgrowth. Development 121,2303-2312
35. Sandy, J. D., Westling, J., Kenagy, R. D., Iruela-Arispe, M. L., Verscharen, C., Rodriguez-Mazaneque, J. C., Zimmermann, D. R., Lemire, J. M., Fischer, J. W., Wight, T.N., and Clowes, A. W. (2001) Versican V1 proteolysis in human aorta in vivo occurs at the Glu441-Ala442 bond, a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4. J. Biol. Chem. 276, 13372-13378
36. Schmalfeldt, M., Bandtlow, C. E., Dours-Zimmermann, M. T., Winterhalter, K. H., and Zimmermann, D. R. (2000) Brain derived versican V2 is a potent inhibitor of axonal growth. J. Cell Sci. 113, 807-816
37. Rodriguez-Manzaneque, J. C., Westling, J., Thai, S. N., Luque, A., Knauper, V., Murphy, G., Sandy, J. D., and Iruela-Arispe, M. L. (2002) AD-AMTS1 cleaves aggrecan at multiple sites and is differentially inhibited by metalloproteinase inhibitors. Biochem. Biophys. Res. Commun. 293, 501-508
38. Fosang, A. J., and Little, C. B. (2008) Drug insight: aggrecanases as therapeutic targets for osteoarthritis. Nat. Clin. Pract. Rheumatol. 4, 420-427
39. Tortorella, M. D., Pratta, M., Liu, R. Q., Austin, J., Ross, O. H., Abbaszade, I., Burn, T., and Amer, E. (2000) Sites of aggrecan cleavage by recombinant human aggrecanase-1 (ADAMTS-4). J. Biol. Chem. 275,18566-18573
40. Lark, M. W., Bayne, E. K., Flanagan, J., Harper, C. F., Hoerrner, L. A., Hutchinson, N. I., Singer, I. I., Donatelli, S. A., Weidner, J. R., Williams, H. R., Mumford, R. A., and Lohmander, L. S. (1997) Aggrecan degradation in human cartilage: evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints. J. Clin. Invest. 100, 93-106
41. Longpré, J. M., McCulloch, D. R., Koo, B. H., Alexander, J. P., Apte, S. S., and Leduc, R. (2009) Characterization of proADAMTS5 processing by proprotein convertases. Int. J. Biochem. Cell Biol. 41,1116-1126
42. Somerville, R. P., Longpre, J. M., Jungers, K. A., Engle, J. M., Ross, M., Evanko, S., Wight, T. N., Leduc, R., and Apte, S. S. (2003) Characterization of ADAMTS-9 and ADAMTS-20 as a distinct AD AMTS subfamily related to Caenorhabditis elegans GON-1. J. Biol. Chem. 278, 9503-9513
43. Dancevic, C. M., Fraser, F. W., Smith, A. D., Stupka, N., Ward, A. C, and McCulloch, D. R. (2013) Biosynthesis and expression of a disintegrin-like and metalloproteinase domain with thrombospondin-1 repeats-15: a novel versican-cleaving proteoglycanase. J. Biol. Chem. 288, 37267-37276
44. Dupuis, L. E., McCulloch, D. R., McGarity, J. D., Bahan, A., Wessels, A., Weber, D., Diminich, A. M., Nelson, C. M., Apte, S. S., and Kern, C. B. (2011) Altered versican cleavage in ADAMTS5 deficient mice: a novel etiology of myxomatous valve disease. Dev. Biol. 357,152-164
45. Dupuis, L. E., Osinska, H., Weinstein, M. B., Hinton, R. B., and Kern, C. B. (2013) Insufficient versican cleavage and Smad2 phosphorylation results in bicuspid aortic and pulmonary valves. J. Mol. Cell. Cardiol. 60, 50-59
46. Kern, C. B., Wessels, A., McGarity, J., Dixon, L. J., Alston, E., Argraves, W. S., Geeting, D., Nelson, C. M., Menick, D. R., and Apte, S. S. (2010) Reduced versican cleavage due to Adamts9 haploinsufficiency is associated with cardiac and aortic anomalies. Matrix Biol. 29, 304-316
47. Russell, D. L, Doyle, K. M., Ochsner, S. A., Sandy, J. D., and Richards, J. S. (2003) Processing and localization of ADAMTS-1 and proteolytic cleavage of versican during cumulus matrix expansion and ovulation. J. Biol. Chem. 278, 42330-42339
48. Silver, D. L., Hou, L., Somerville, R., Young, M. E., Apte, S. S., Pavan, W. J. (2008) The secreted metalloprotease ADAMTS20 is required for melanoblast survival. PLoS Genet. 4, e1000003
49. Longpré, J. M., and Leduc, R. (2004) Identification of prodomain determinants involved in ADAMTS-1 biosynthesis. J. Biol. Chem. 279, 33237-33245
50. Dutt, S., Cassoly, E., Dours-Zimmermann, M. T., Matasci, M., Stoeckli, E. T., and Zimmermann, D. R. (2011) Versican V0 and V1 direct the growth of peripheral axons in the developing chick hindlimb. J. Neurosci. 31, 5262-5270
51. Bai, X., Wei, G., Sinha, A., and Esko, J.D. (1999) Chinese hamster ovary cell mutants defective in glycosaminoglycan assembly and glucuronosyltransferase I. J. Biol. Chem. 274,13017-13024
52. Victor, X. V., Nguyen, T. K., Ethirajan, M., Tran, V. M., Nguyen, K. V., and Kuberan, B. (2009) Investigating the elusive mechanism of glycosaminoglycan biosynthesis. J. Biol. Chem. 284, 25842-25853
53. Brown, H. M., Dunning, K. R., Robker, R. L., Boerboom, D., Pritchard, M., Lane, M., and Russell, D. L. (2010) ADAMTS1 cleavage of versican mediates essential structural remodeling of the ovarian follicle and cumulusoocyte matrix during ovulation in mice. Biol. Reprod. 83, 549-557
54. Brown, H. M., Dunning, K. R., Robker, R. L., Pritchard, M., and Russell, D. L. (2006) Requirement for ADAMTS-1 in extracellular matrix remodeling during ovarian folliculogenesis and lymphangiogenesis. Dev. Biol. 300, 699-709
55. Stankunas, K., Hang, C. T., Tsun, Z. Y., Chen, H., Lee, N. V., Wu, J. I., Shang, C., Bayle, J. H., Shou, W., Iruela-Arispe, M. L., and Chang, C. P. (2008) Endocardial Brg1 represses ADAMTS1 to maintain the microenvironment for myocardial morphogenesis. Dev. Cell 14, 298-311
56. Mosyak, L., Georgiadis, K., Shane, T., Svenson, K., Hebert, T., McDonagh, T., Mackie, S., Oil and, S., Lin, L., Zhong, X., Kriz, R., Reifenberg, E. L., Collins-Racie, L. A., Corcoran, C., Freeman, B., Zollner, R., Marvell, T., Vera, M., Sum, P. E., Lavallie, E. R., Stahl, M., and Somers, W. (2008) Crystal structures of the two major aggrecan degrading enzymes, ADAMTS4 and ADAMTS5. Protein Sci. 17,16-21
57. Ilic, M. Z., Handley, C. J., Robinson, H. C, and Mok, M. T. (1992) Mechanism of catabolism of aggrecan by articular cartilage. Arch. Biochem. Biophys. 294,115-122
58. Hering, T. M., Kollar, J., and Huynh, T. D. (1997) Complete coding sequence of bovine aggrecan: comparative structural analysis. Arch. Biochem. Biophys. 345, 259-270
59. Munteanu, S. E., Ilic, M. Z., and Handley, C. J. (2002) Highly sulfated glycosaminoglycans inhibit aggrecanase degradation of aggrecan by bovine articular cartilage explant cultures. Matrix Biol. 21, 429-440
60. Miwa, H. E., Gerken, T. A., and Hering, T. M. (2006) Effects of covalently attached chondroitin sulfate on aggrecan cleavage by ADAMTS-4 and MMP-13. Matrix Biol. 25, 534-545
61. Tortorella, M., Pratta, M., Liu, R. Q., Abbaszade, I., Ross, H., Burn, T., and Arner, E. (2000) The thrombospondin motif of aggrecanase-1 (ADAMTS-4) is critical for aggrecan substrate recognition and cleavage. J Biol. Chem. 275, 25791-25797
62. Gendron, C., Kashiwagi, M., Lim, N. H., Enghild, J. J., Thøgersen, I. B., Hughes, C., Caterson, B., and Nagase, H. (2007) Proteolytic activities of human ADAMTS-5: comparative studies with ADAMTS-4. J. Biol. Chem. 282,18294-18306
63. Kashiwagi, M., Enghild, J. J., Gendron, C., Hughes, C., Caterson, B., Itoh, Y., and Nagase, H. (2004) Altered proteolytic activities of ADAMTS-4 expressed by C-terminal processing. J. Biol. Chem. 279,10109-10119
64. Kuno, K., and Matsushima, K. (1998) ADAMTS-1 protein anchors at the extracellular matrix through the thrombospondin type I motifs and its spacing region. J. Biol. Chem. 273,13912-13917
65. Fushimi, K., Troeberg, L., Nakamura, H., Lim, N. H., and Nagase, H. (2008) Functional differences of the catalytic and non-catalytic domains in human ADAMTS-4 and ADAMTS-5 in aggrecanolytic activity. J. Biol. Chem. 283, 6706-6716
66. Akiyama, M., Takeda, S., Kokame, K., Takagi, J., and Miyata, T. (2009) Crystal structures of thenoncatalytic domains of ADAMTS13 reveal multiple discontinuous exosites for von Willebrand factor. Proc. Natl. Acad. Sci. U.S.A. 106,19274-19279
67. Zheng, X. L., Wu, H. M., Shang, D., Falls, E., Skipwith, C. G., Cataland, S. R., Bennett, C. L., and Kwaan, H. C. (2010) Multiple domains of ADAMTS13 are targeted by autoantibodies against ADAMTS13 in patients with acquired idiopathic thrombotic thrombocytopenic purpura. Haematologica 95, 1555-1562
68. Zheng, X. L. (2013) Structure-function and regulation of ADAMTS-13 protease. J. Thromb. Haemost. 11,11-23
69. Matthews, R. T., Gary, S. C., Zerillo, C., Pratta, M., Solomon, K., Arner, E. C., and Hockfield, S. (2000) Brain-enriched hyaluronan binding (BEHAB)/brevican cleavage in a glioma cell line is mediated by a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) family member. J. Biol. Chem. 275, 22695-22703
70. Viapiano, M. S., Hockfield, S., and Matthews, R. T. (2008) BEHAB/brevican requires ADAMTS-mediated proteolytic cleavage to promote glioma invasion. J. Neurooncol. 88, 261-272